UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants

PLoS pathogens, 2022-02, Vol.18 (2), p.e1010260-e1010260

2022

Volltextzugriff (PDF)

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

Clinical cancer research, 2015-02, Vol.21 (4), p.870-881

2015

Volltextzugriff (PDF)

Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials

Translational oncology, 2022-07, Vol.21, p.101426-101426, Article 101426

2022

Volltextzugriff (PDF)

Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer

Clinical cancer research, 2019-09, Vol.25 (17), p.5315-5328

2019

Volltextzugriff (PDF)

Pan-Cancer Analysis Shows Enrichment of Macrophages, Overexpression of Checkpoint Molecules, Inhibitory Cytokines, and Immune Exhaustion Signatures in EMT-High Tumors

Frontiers in oncology, 2022-01, Vol.11, p.793881-793881

2022

Volltextzugriff (PDF)

Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck

Clinical cancer research, 2017-08, Vol.23 (16), p.4897-4907

2017

Volltextzugriff (PDF)

Low expression of TMPRSS2–a SARS-CoV-2 internalization protease–associates with basal subtype of head and neck squamous cell carcinoma

Translational oncology, 2022-08, Vol.22, p.101458-101458, Article 101458

2022

Volltextzugriff (PDF)

A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Clinical cancer research, 2012-04, Vol.18 (8), p.2336-2343

2012

Volltextzugriff (PDF)

Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment

Diseases, 2022-11, Vol.10 (4), p.114

2022

Volltextzugriff (PDF)

Growth factor expression mediates resistance to EGFR inhibitors in head and neck squamous cell carcinomas

Oral oncology, 2016-05, Vol.56, p.62-70

2016

Volltextzugriff (PDF)

Identification and Evaluation of Apoptosis-Inducing Activity of Ipomone from Ipomoea nil: A Novel, Unusual Bicyclo-[3.2.1] Octanone Containing Gibberic Acid Diterpenoid

ACS omega, 2021-03, Vol.6 (12), p.8253-8260

2021

Volltextzugriff (PDF)

Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants

PLoS pathogens, 2022-02, Vol.18 (2), p.e1010260

2022

Volltextzugriff (PDF)

Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors

Cancer, 2021-12, Vol.127 (24), p.4565-4573

2021

Volltextzugriff (PDF)

Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab

Cancer gene therapy, 2024-07

2024

Volltextzugriff (PDF)

Immune profiles in primary squamous cell carcinoma of the head and neck

Oral oncology, 2019-09, Vol.96, p.77-88

2019

Volltextzugriff (PDF)

Association of DRB1 and DRBQ haplotype 04:01~03:01 with HPV positive head and neck squamous cell carcinoma

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.6054-6054

2017

Volltextzugriff (PDF)

Mechanism of acquired resistance to cetuximab in head and neck cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18061-e18061

2018

Volltextzugriff (PDF)

Immune escape correlates with an inflamed phenotype in malignant mesothelioma

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.7566-7566

2015

Volltextzugriff (PDF)

Biomarkers of pembrolizumab (P) activity in mesothelioma (MM): Results from a phase II trial

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.8557-8557

2017

Volltextzugriff (PDF)

Association of a baseline neutrophil-to-lymphocyte ratio (NLR) with progression-free and overall survival in head and neck cancer patients receiving anti-PD-1 therapy

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6038-6038

2018

Volltextzugriff (PDF)

High-accuracy HPV testing versus p16 IHC using multiple clinically relevant outcomes: The University of Chicago Experience

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6020-6020

2018

Volltextzugriff (PDF)

Association of immune-related adverse events (irAEs) with improved response, progression-free survival, and overall survival for patients with metastatic head and neck cancer receiving anti-PD-1 therapy

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6014-6014

2018

Volltextzugriff (PDF)

Association of low serum albumin concentration with reduced overall survival for patients with metastatic head and neck cancer receiving anti-programmed death receptor-1 therapy

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6057-6057

2018

Volltextzugriff (PDF)

Abstract 1847: Influence of growth factors on resistance to EGFR inhibitor treatment in HNSCC - Temsirolimus as a potential concept

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1847-1847

2014

Volltextzugriff (PDF)

Biomarker-driven indication selection in JTX-2011 ICONIC clinical trial

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.11602-11602

2017

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Oncology
(13)
Humans
(12)
Male
(7)
Female
(5)
Adult
(4)
Immunotherapy
(4)
Middle Aged
(4)
Tumors
(4)
Aged
(3)
Biological And Medical Sciences
(3)
Cancer
(3)
Dentistry, Oral Surgery & Medicine
(3)
Head And Neck Neoplasms - Drug Therapy
(3)
Head And Neck Neoplasms - Genetics
(3)
Head And Neck Neoplasms - Pathology
(3)
Hematology, Oncology And Palliative Medicine
(3)
Immune Checkpoints
(3)
Medical Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials

Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer

Pan-Cancer Analysis Shows Enrichment of Macrophages, Overexpression of Checkpoint Molecules, Inhibitory Cytokines, and Immune Exhaustion Signatures in EMT-High Tumors

Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck

Low expression of TMPRSS2–a SARS-CoV-2 internalization protease–associates with basal subtype of head and neck squamous cell carcinoma

A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment

Growth factor expression mediates resistance to EGFR inhibitors in head and neck squamous cell carcinomas

Identification and Evaluation of Apoptosis-Inducing Activity of Ipomone from Ipomoea nil: A Novel, Unusual Bicyclo-[3.2.1] Octanone Containing Gibberic Acid Diterpenoid

Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants

Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors

Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab

Immune profiles in primary squamous cell carcinoma of the head and neck

Association of DRB1 and DRBQ haplotype 04:01~03:01 with HPV positive head and neck squamous cell carcinoma

Mechanism of acquired resistance to cetuximab in head and neck cancer

Immune escape correlates with an inflamed phenotype in malignant mesothelioma

Biomarkers of pembrolizumab (P) activity in mesothelioma (MM): Results from a phase II trial

Association of a baseline neutrophil-to-lymphocyte ratio (NLR) with progression-free and overall survival in head and neck cancer patients receiving anti-PD-1 therapy

High-accuracy HPV testing versus p16 IHC using multiple clinically relevant outcomes: The University of Chicago Experience

Association of immune-related adverse events (irAEs) with improved response, progression-free survival, and overall survival for patients with metastatic head and neck cancer receiving anti-PD-1 therapy

Association of low serum albumin concentration with reduced overall survival for patients with metastatic head and neck cancer receiving anti-programmed death receptor-1 therapy

Abstract 1847: Influence of growth factors on resistance to EGFR inhibitor treatment in HNSCC - Temsirolimus as a potential concept

Biomarker-driven indication selection in JTX-2011 ICONIC clinical trial

Suchergebnisse filtern